Nestle shares at two-year low as investors weigh Wegovy rollout
Nestle shares were under pressure on Friday as investors weighed the potential impact of Novo Nordisk's blockbuster weight-losing
1970-01-01 08:00
The maker of Wegovy and Ozempic is now Europe's most valuable company
Novo Nordisk has dethroned Bernard Arnault's luxury goods giant LVMH as Europe's most valuable company.
1970-01-01 08:00
How soaring demand for Ozempic and Wegovy is altering Denmark's economy
The dazzling success of weight-loss drugs in the United States is leading to lower interest rates in Denmark, home of one of their biggest manufacturers, according to the Nordic country's biggest bank.
1970-01-01 08:00